http://www.pharmexec.com/pharmexec/Top+Feature/Article/list/49659 The publisher of Pharmaceutical Executive brings visitors PharmExec.com, which serves up a daily dose of news and features from the world of pharma business and marketing. 2013-05-21T22:36:58Z http://www.pharmexec.com/pharmexec/Marketing/Evidence-Based-Marketing-From-Rise-to-Stallmdashan/ArticleStandard/Article/detail/810227?contextCategoryId=49659&ref=25 The slow evolution toward a state of grace in tracking ROI for digital promotion. 2013-04-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/152013/810227/Evidencebasedmarketing_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Top+Feature/India-Prepares-for-BioPharm-Push/ArticleStandard/Article/detail/808192?contextCategoryId=49659&ref=25 New guidelines on good distribution practices for biologics will have a significant impact on the Indian pharma sector — for good or ill. Jane Wan reports. 2013-03-15T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/112013/808192/India-flag-top-feature_flash.jpg XML http://www.pharmexec.com/pharmexec/Profiles/Pharma-in-the-News-Pharm-Execs-Annual-Press-Audit/ArticleStandard/Article/detail/808527?contextCategoryId=49659&ref=25 Big Pharma takes a fresh licking in our latest audit of US press coverage of business and policy issues. 2013-03-01T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/122013/808527/newspapers_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Top+Feature/Pharmacies-mdash-A-New-Patient-Education-Opportuni/ArticleStandard/Article/detail/806473?contextCategoryId=49659&ref=25 Kenneth Getz of the Tufts Center for the Study of Drug Development looks at leveraging pharmacists as a channel to raise clinical research literacy among patient communities. 2013-02-25T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/092013/806473/pharmacy_drawer_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Back+Page/NHTSA-Addresses-Drugged-Driving/ArticleStandard/Article/detail/806582?contextCategoryId=49659&ref=25 After years of asking questions, the National Highway Traffic Safety Administration (NHTSA)is moving closer to a protocol "for assessing the driving-impairment risks of drugs". Ben Comer reports. 2013-02-01T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/092013/806582/drugged_driving_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Europe/The-Puzzle-Master-EMAs-Guido-Rasi/ArticleStandard/Article/detail/799841?contextCategoryId=49659&ref=25 Europe's chief regulator charts a strategy from many moving parts. Dr Guido Rasi talks to Pharm Exec's William Looney. 2012-12-01T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/502012/799841/Rasi_flash.jpg XML http://www.pharmexec.com/pharmexec/Technology/To-Mobile-App-or-Not-to-Mobile-App-That-is-the-IT-/ArticleStandard/Article/detail/795207?contextCategoryId=49659&ref=25 If we swallow the hype and decide that we all need to get onto the mobile app bandwagon, how exactly do we go about it? Sven Awege explains. 2012-11-05T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/452012/795207/ipad-176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Strategy/Your-Local-Competitor-A-Threat-in-Emerging-Markets/ArticleStandard/Article/detail/791513?contextCategoryId=49659&ref=25 Pharmaceutical companies looking to wrest market share in high growth markets of tomorrow must overcome challenges from a new crop of national champions. 2012-10-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/402012/791513/world_emerging_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Back+Page/The-Power-of-Patient-Feedback/ArticleStandard/Article/detail/788394?contextCategoryId=49659&ref=25 Specialized knowledge about disease and treatment is no longer the exclusive province of practicing physicians. Patient voices are increasing in volume, along with their roles in treatment decisions. 2012-09-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/372012/788394/patient_social_media_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Top+Feature/Emerging-Pharma-Leaders-David-Ford/ArticleStandard/Article/detail/783244?contextCategoryId=49659&ref=25 Are there parallels between milk and medicine? To David Ford, a native New Zealander who now runs Sanofi's North America human resources operations, the answer is a qualified yes. 2012-07-30T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/312012/783244/David_Ford_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Top+Feature/Emerging-Pharma-Leaders-Georg-Toufar/ArticleStandard/Article/detail/782475?contextCategoryId=49659&ref=25 Pharma's Baby Boomer era is over — now it's the Generation X-ers' turn, says Georg Toufar, Chief Marketing Officer and Board Director of Mundipharma International Limited. 2012-07-24T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/302012/782475/Georg-Toufar_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Top+Feature/Emerging-Pharma-Leaders-Eric-Dube/ArticleStandard/Article/detail/781929?contextCategoryId=49659&ref=25 Eric Dube, one of this years Pharm Exec Emerging Pharma Leaders, is not yet 40 and is now GSK's senior VP of strategy after already holding seven "very different" roles at the company. 2012-07-18T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/292012/781929/Dube_Eric_head-shot_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Top+Feature/Emerging-Lessons-from-the-Emerging-Markets/ArticleStandard/Article/detail/780216?contextCategoryId=49659&ref=25 It's good to look to other industries such as FMCG — and to products such as Pepsi and Horlicks — for lessons in emerging market success, writes Nick Stephens. 2012-07-04T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/272012/780216/nick-stephens_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/R%26D/Raising-the-Stakes-in-CNS/ArticleStandard/Article/detail/777872?contextCategoryId=49659&ref=25 As brands are required to produce more and more data to convince not only regulators, but payers, physicians, and patients, Jeffrey Jonas is pushing Shire's "search and develop" R&D model into new and sometimes uncomfortable territory. 2012-06-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/242012/777872/Photo-JJona-176_flash.gif XML http://www.pharmexec.com/pharmexec/Top+Feature/Comparative-Effectiveness-Research-Challenges-for-/ArticleStandard/Article/detail/772674?contextCategoryId=49659&ref=25 Switching Rx drugs to OTC and adding comparative data could broaden access to treatment, writes Jill Wechsler. 2012-05-09T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/192012/772674/hurdle_176_flash.jpg HTML http://www.pharmexec.com/pharmexec/Executive+Profiles/Emerging-Markets-Setting-a-New-Agenda/ArticleStandard/Article/detail/767911?contextCategoryId=49659&ref=25 India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries. 2012-04-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/142012/767911/Mashelkar-Photo_176_flash.jpg XML http://www.pharmexec.com/pharmexec/Article/Time-to-Appoint-a-Chief-Patient-Officer/ArticleStandard/Article/detail/757969?contextCategoryId=49659&ref=25 Sarah Krug asks if it is time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust. 2012-02-01T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/062012/757969/patient2_flash.jpg XML http://www.pharmexec.com/pharmexec/Top+Feature/Leadership-in-a-Lean-Market/ArticleStandard/Article/detail/737037?contextCategoryId=49659&ref=25 Can lean management be a driver of innovation? Find out what Pharm Exec's 2011 Emerging Pharma Leaders think in this series of exclusive podcast interviews. 2011-08-25T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/352011/737037/Emerging-Inc-Art.TopFeature_flash.jpg HTML http://www.pharmexec.com/pharmexec/From+the+Editor/Options-for-Paying-for-HealthmdashThe-Right-Way/ArticleStandard/Article/detail/734669?contextCategoryId=49659&ref=25 What Big Pharma fails to see is how engagement in health policy is the biggest of reputation builders 2011-08-01T04:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322011/734669/numbered-pills_main.jpg http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/322011/734669/numbered-pills_flash.jpg XML http://www.pharmexec.com/pharmexec/Top+Feature/India-to-Double-Pharmaceutical-Exports-by-2014/ArticleStandard/Article/detail/757923?contextCategoryId=49659&ref=25 With the $12-billion valued Indian pharma industry expected to grow at a CAGR of 16%, the Indian government plans to capitalize on the growth potential in an effort to beat the competition. 2012-02-02T05:00:00Z http://www.pharmexec.com/pharmexec/data/articlestandard/pharmexec/062012/757923/India-flag-top-feature_flash.jpg XML